Furthermore, through the CNC networks, ceRNA networks, RT-PCR, and functional analysis, we identified hsa_circRNA_012448-hsa-miR-29b-2-5p-GSK3β as a potential signaling pathway mediating the protective effects of dapagliflozin on DKD. The gene discussed is GSK3B; the disease is diabetic kidney disease.